Literature DB >> 19506469

Outcomes of vascular access creation prior to dialysis: building the case for early referral.

Catherine L Weber1, Ognjenka Djurdjev, Adeera Levin, Mercedeh Kiaii.   

Abstract

A 2-year single institution experience of the successes and complications of arteriovenous fistula (AVF) creation before dialysis initiation is reported. Study cohort: all patients who underwent AVF creation before need for dialysis (AVF group, n = 125). "Control" group: all patients with a sustained glomerular filtration rate (GFR) <or=25 ml/min and eligible for AVF creation during the same time period, but did not have an access placed before dialysis (no AVF group, n = 198). Median nephrology contact time was >12 months in both groups and mean eGFR at creation (AVF group) was 12 ml/min. In the AVF group, 72% underwent a successful first AVF creation, 11% suffered AVF thrombosis, and 17% had a nonmaturing AVF before need for dialysis. Sixty-six percent (n = 23) of these latter patients underwent a second AVF creation and 48% were mature at dialysis initiation. During the study period, 70% (n = 88, AVF group) and 61% (n = 121, no AVF group) commenced dialysis. Impressively, 72% (n = 66) of the AVF group used a mature fistula as their first dialysis access. A snapshot of "access in use" at the 6-month mark of dialysis revealed the AVF group had a higher number of patients using an AVF (81% vs. 44%) and a lower number with catheters (19% vs. 56%, respectively, p = 0.001). In conclusion, the success rate of early AVF creation is reasonable and complications when identified can be remedied without the need for a catheter, thus ultimately maximizing the use of AVF in dialysis patients.

Entities:  

Mesh:

Year:  2009        PMID: 19506469     DOI: 10.1097/MAT.0b013e31819f635c

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  8 in total

1.  Vascular access creation before hemodialysis initiation and use: a population-based cohort study.

Authors:  Ahmed A Al-Jaishi; Charmaine E Lok; Amit X Garg; Joyce C Zhang; Louise M Moist
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

2.  Outcomes of Elderly Patients after Predialysis Vascular Access Creation.

Authors:  Timmy Lee; Mae Thamer; Yi Zhang; Qian Zhang; Michael Allon
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

3.  Likelihood of starting dialysis after incident fistula creation.

Authors:  Matthew J Oliver; Robert R Quinn; Amit X Garg; S Joseph Kim; Ron Wald; J Michael Paterson
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

4.  Multiple preoperative and intraoperative factors predict early fistula thrombosis in the Hemodialysis Fistula Maturation Study.

Authors:  Alik Farber; Peter B Imrey; Thomas S Huber; James M Kaufman; Larry W Kraiss; Brett Larive; Liang Li; Harold I Feldman
Journal:  J Vasc Surg       Date:  2016-01       Impact factor: 4.268

5.  Timing of preemptive vascular access placement: do we understand the natural history of advanced CKD?: an observational study.

Authors:  Nisha Bansal; Chenyin He; Daniel P Murphy; Kirsten L Johansen; Chi-yuan Hsu
Journal:  BMC Nephrol       Date:  2013-05-28       Impact factor: 2.388

6.  Renal function, uraemia and early arteriovenous fistula failure.

Authors:  Emma Aitken; Andrew Jackson; Chia Kong; Paul Coats; David Kingsmore
Journal:  BMC Nephrol       Date:  2014-11-17       Impact factor: 2.388

7.  Arteriovenous Vascular Access Selection and Evaluation.

Authors:  Jennifer M MacRae; Matthew Oliver; Edward Clark; Christine Dipchand; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Charmaine Lok; Rick Luscombe; Lisa M Miller; Louise Moist
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

8.  Bridge of Tunneled Cuffed Catheter as a Risk for Future Arteriovenous Fistulae Failure.

Authors:  Chung-Kuan Wu; Yen-Chun Huang; Chia-Hsun Lin; Mingchih Chen
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.